349 related articles for article (PubMed ID: 25633802)
1. Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.
Nakata H; Miyazaki T; Iwasaki T; Nakamura A; Kidani T; Sakayama K; Masumoto J; Miura H
Oncol Rep; 2015 Apr; 33(4):1593-8. PubMed ID: 25633802
[TBL] [Abstract][Full Text] [Related]
2. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma.
Chen B; Yang JZ; Wang LF; Zhang YJ; Lin XJ
BMC Cancer; 2015 Oct; 15():752. PubMed ID: 26486165
[TBL] [Abstract][Full Text] [Related]
4. The antitumor effect of liposome-encapsulated cisplatin on rat osteosarcoma and its enhancement by caffeine.
Karita M; Tsuchiya H; Kawahara M; Kasaoka S; Tomita K
Anticancer Res; 2008; 28(3A):1449-57. PubMed ID: 18630498
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of the antitumor effect of calcium phosphate cement containing anticancer drug and caffeine on rat osteosarcoma.
Tanzawa Y; Tsuchiya H; Shirai T; Nishida H; Hayashi K; Takeuchi A; Kawahara M; Tomita K
J Orthop Sci; 2011 Jan; 16(1):77-84. PubMed ID: 21360005
[TBL] [Abstract][Full Text] [Related]
6. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
[TBL] [Abstract][Full Text] [Related]
7. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma.
Tomita K; Tsuchiya H
Clin Ther; 1989; 11(1):43-52. PubMed ID: 2720727
[TBL] [Abstract][Full Text] [Related]
9. Antimetastatic activity of honokiol in osteosarcoma.
Steinmann P; Walters DK; Arlt MJ; Banke IJ; Ziegler U; Langsam B; Arbiser J; Muff R; Born W; Fuchs B
Cancer; 2012 Apr; 118(8):2117-27. PubMed ID: 21935912
[TBL] [Abstract][Full Text] [Related]
10. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice.
Badary OA
J Ethnopharmacol; 1999 Nov; 67(2):135-42. PubMed ID: 10619376
[TBL] [Abstract][Full Text] [Related]
12. Caffeine dose-dependently potentiates the antitumor effect of cisplatin on osteosarcomas.
Kawahara M; Takahashi Y; Takazawa K; Tsuchiya H; Tomita K; Yokogawa K; Miyamoto K
Anticancer Res; 2008; 28(3A):1681-5. PubMed ID: 18630526
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide induces acute renal failure via inhibition of the thioredoxin reductase activity.
Zhang J; Lu H
Free Radic Biol Med; 2007 Dec; 43(12):1574-83. PubMed ID: 18037123
[TBL] [Abstract][Full Text] [Related]
14. BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma.
Gobin B; Huin MB; Lamoureux F; Ory B; Charrier C; Lanel R; Battaglia S; Redini F; Lezot F; Blanchard F; Heymann D
Int J Cancer; 2015 Feb; 136(4):784-96. PubMed ID: 24961790
[TBL] [Abstract][Full Text] [Related]
15. Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.
Duan X; Jia SF; Koshkina N; Kleinerman ES
Cancer; 2006 Mar; 106(6):1382-8. PubMed ID: 16453328
[TBL] [Abstract][Full Text] [Related]
16. [Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center].
Roguin A; Ben Arush MW; Higasi A; Kuten A
Harefuah; 1996 Apr; 130(8):511-4, 584. PubMed ID: 8765870
[TBL] [Abstract][Full Text] [Related]
17. Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide.
Sancéau J; Poupon MF; Delattre O; Sastre-Garau X; Wietzerbin J
Oncogene; 2002 Oct; 21(50):7700-9. PubMed ID: 12400012
[TBL] [Abstract][Full Text] [Related]
18. The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
Sasaki Y; Kjellén E; Ekblad L; Wahlberg P; Mineta H; Wennerberg J
Oral Oncol; 2012 Jan; 48(1):61-6. PubMed ID: 21963040
[TBL] [Abstract][Full Text] [Related]
19. Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma.
Tsuchiya H; Mori Y; Ueda Y; Okada G; Tomita K
Anticancer Res; 2000; 20(1A):235-42. PubMed ID: 10769661
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anti-tumor effects of novel Span 80 vesicles containing immobilized Eucheuma serra agglutinin.
Omokawa Y; Miyazaki T; Walde P; Akiyama K; Sugahara T; Masuda S; Inada A; Ohnishi Y; Saeki T; Kato K
Int J Pharm; 2010 Apr; 389(1-2):157-67. PubMed ID: 20100554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
